KORU Medical Systems, Inc. (KRMD) vs Nyxoah S.A. (NYXH)

A side-by-side comparison of KORU Medical Systems, Inc. and Nyxoah S.A. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — KRMD vs NYXH

growth of $100 · dividends reinvested · last 5y
KRMD -7.4% (-1.5%/yr)NYXH -94.1% (-43.3%/yr)KRMD compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $10020222023202420252026$93$6
KRMD NYXH

KRMD vs NYXH: by the numbers

  • •NYXH is the larger company ($143M vs $137M market cap).
  • •Both run net losses; KRMD's is the smaller (-4.03% vs -435.70% net margin).
  • •NYXH grew revenue faster over the past five years (120.68% vs 16.42% CAGR).

Metrics side by side

Valuation

MetricKRMDNYXH
P/S ratio3.035.46
P/B ratio7.581.51
FCF yield0.19%N/A

Profitability

MetricKRMDNYXH
Gross margin61.99%63.13%
Operating margin-3.66%-827.76%
Net margin-4.03%-435.70%
ROE-10.08%-120.33%
ROIC-7.95%-61.13%

Growth (annualized)

MetricKRMDNYXH
Revenue CAGR (5Y)16.42%120.68%
Total return CAGR (5Y)1.60%-45.84%

Frequently asked

Which has grown faster, KRMD or NYXH?
Over the past five years, NYXH grew revenue faster — KRMD at a 16.42% CAGR versus NYXH at 120.68%.
How have KRMD and NYXH total returns compared?
Over the past 5 years, KRMD delivered 1.60% and NYXH delivered -45.84% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.